🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Nuvation Bio Inc.

NUVB Healthcare
$4.72 $-0.06 (-1.26%)
Market Cap: $1.64 B
Gurus Holding
7
Popularity Rank
#1073
% of Shares Held
1.06%
Net Activity (Q1 2026)
-$8.05 M

Guru Ownership Trend

Guru Analysis for Nuvation Bio Inc. (NUVB)

Nuvation Bio Inc. (NUVB), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $17.42 M.

Top institutional holders include Cliff Asness and David Abrams.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $8.05 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, David Abrams reduced exposure by 66.7%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$2.85 M
Total Buy Value
New Buys 2
Additions 0
-$10.9 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Nuvation Bio Inc. (NUVB)

Major holders include Cliff Asness ($14.96 M), David Abrams ($5.45 M), Renaissance Technologies (RenTech) ($2.4 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 3.69 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $8.05 M, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited NUVB. The total reported sell value was $10.9 M.

Yes, 2 managers opened new positions in NUVB, and 0 increased their existing holdings. The total reported buy value was $2.85 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Reduce -18.0% 1,669,166 $14.96 M Q4 2025
0.12% Reduce -66.7% 1,270,504 $5.45 M Q1 2026
0.00% New Buy 559,180 $2.4 M Q1 2026
0.10% New Buy 105,000 $450,450 Q1 2026
0.01% 34,995 $313,555 Q4 2025
0.00% Add 83.2% 31,269 $280,170 Q4 2025
0.00% New Buy 19,588 $175,508 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form